03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Danol 200mg* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Sanofi |
Responsible Party | Sanofi Winthrop |
Origin | UK |
Manufacturer | Sanofi Winthrop |
Origin | UK |
ATC | G03XA01 |
Danol 200mg* :
Danol 200mg* :
Danol 200mg* :
Danol 200mg* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Danol 200mg* :
Danol 200mg* :
Danol 200mg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
5'nucleotidase increased | Not known |
Acne | Not known |
Amenorrhoea (amenorrhea) | Not known |
Anxiety | Not known |
Apolipoprotein A-I decreased | Not known |
Apolipoprotein A-II decreased | Not known |
Arterial thrombosis | Not known |
Arthralgia (Pain joint) (Joint ache) | Not known |
Back pain | Not known |
Benign intracranial hypertension | Not known |
Breast atrophy | Not known |
Carpal tunnel syndrome | Not known |
Cerebral thrombosis | Not known |
Creatine phosphokinase increased | Not known |
Depressed mood | Not known |
Dermatitis exfoliative | Not known |
Dizziness | Not known |
Emotional lability | Not known |
Enlarged clitoris | Not known |
Eosinophilia | Not known |
Epigastralgia (Epigastric pain) | Not known |
Epilepsy aggravated | Not known |
Erythema multiforme | Not known |
Face oedema | Not known |
Fasciculation (Muscle fasciculation) | Not known |
Fatigue | Not known |
Fluid retention | Not known |
Flushing | Not known |
Focal nodular hyperplasia | Not known |
Glucagon increased | Not known |
Glucose tolerance impaired | Not known |
Hair loss | Not known |
HDL cholesterol decreased | Not known |
Headache | Not known |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Not known |
Hepatocellular injury | Not known |
Hirsutism | Not known |
Hoarseness | Not known |
Hypertension | Not known |
Increased appetite | Not known |
Insulin resistance | Not known |
Interstitial pneumonitis | Not known |
Jaundice cholestatic (Cholestatic icterus) | Not known |
Jaundice hepatocellular | Not known |
Joint swelling | Not known |
LDL Increased | Not known |
Leucopenia (Leukopenia) | Not known |
Libido disorder | Not known |
Malignant hepatic neoplasm | Not known |
Menstrual disorder | Not known |
Migraine | Not known |
Muscle cramps | Not known |
Myocardial infarction | Not known |
Nausea | Not known |
Nervousness | Not known |
Nodule | Not known |
Pain in extremity (Pain in limb) | Not known |
Pain pharynx (Throat sore) | Not known |
Palpitations | Not known |
Pancreatitis | Not known |
Peliosis hepatis | Not known |
Pigmentation skin | Not known |
Platelet count increased | Not known |
Pleuritic pain | Not known |
Polycythaemia | Not known |
Poor concentration | Not known |
Red blood cell count increased | Not known |
Sagittal sinus thrombosis | Not known |
Seborrhoea | Not known |
Serum transaminase increased | Not known |
Skin rash | Not known |
Spermatogenesis abnormal | Not known |
Splenic peliosis | Not known |
Spotting between menses (Intermenstrual bleeding) | Not known |
Tachycardia | Not known |
Thrombocytopenia (Thrombopenia) | Not known |
Thrombotic events | Not known |
Thyroid binding globulin decreased | Not known |
Vaginal dryness | Not known |
Vaginal irritation | Not known |
Vertigo | Not known |
Vision blurred | Not known |
Visual disturbance | Not known |
Voice disturbance | Not known |
Weight increased (weight gain) | Not known |
Danol 200mg* :
Different Units By MoH Code
Danol 200mg* MoH 1907 :
Form | Capsule, hard |
Packaging | Blisters (Al/PVC) |
Package Size | Box of 100 |
Strength | 200mg |
Storage Condition | <30°C None |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 78711 |
Submission date | 01/01/1997 |
Registration Year | 1997 |
Archived Date | 2014 |
Price Comparison
● Country: | Qatar | |
● Package Size: | 100 | |
● Public Price: | 384 QAR | ( 9,430,272.00 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 3,84 QAR | ( 73,674.00 LBP ) |
● Pharmacy Price: | 315.49315096 QAR | ( 7747880.8012757 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 100 | |
● Public Price: | 369.5 AED | ( 8,927,489.50 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 3,695 AED | ( 72,483.00 LBP ) |
● Pharmacy Price: | 305.73 AED | ( 7386742.53 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 100's | |
● Public Price: | 369.5 AED | ( 8,927,489.50 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 3,695 AED | ( 72,483.00 LBP ) |
● Pharmacy Price: | 305.73 AED | ( 7386742.53 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 60 | |
● Public Price: | 206.2 SAR | ( 4,874,568.00 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 3,4367 SAR | ( 70,920.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Kuweit | |
● Package Size: | 100 | |
● Public Price: | 31.51 KWD | ( 9,250,737.31 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 0,3151 KWD | ( 0.00 LBP ) |
● Pharmacy Price: | 26.62 KWD | ( 7815126.22 LBP ) |
● Pricing Date: | 07/02/2021 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File